Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 44 percent decrease over losses of $(0.25) per share from the same period last year.
Southwest Gas Unit Centuri Gears Up For IPO: Details
Centuri, a subsidiary of Southwest Gas Holdings, is launching an IPO of 12.4M shares on NYSE with an option for 1.86M more, priced between $18-$21. Carl Icahn's entities also plan to invest.